{"id":61621,"date":"2025-07-22T22:03:42","date_gmt":"2025-07-22T20:03:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/avvio-medical-announces-new-cpt-code-for-its-breakthrough-kidney-stone-treatment-technology\/"},"modified":"2025-07-22T22:03:42","modified_gmt":"2025-07-22T20:03:42","slug":"avvio-medical-announces-new-cpt-code-for-its-breakthrough-kidney-stone-treatment-technology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/avvio-medical-announces-new-cpt-code-for-its-breakthrough-kidney-stone-treatment-technology\/","title":{"rendered":"Avvio Medical Announces New CPT Code for Its Breakthrough Kidney Stone Treatment Technology"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–Avvio Medical, Inc<\/a>., a company dedicated to revolutionizing the treatment of urinary stones, is excited to announce that the American Medical Association (AMA) has officially published the early release of a new Category III CPT code for Avvio\u2019s novel kidney stone treatment system.<\/p>\n

<\/a>
<\/a><\/p>\n

\nEffective January 1, 2026<\/strong>, CPT code 0991T <\/b>will be used by healthcare providers and facilities nationwide to report procedures utilizing Avvio Medical\u2019s innovative technology. The new code, which reflects the final nomenclature approved by the AMA, marks a significant milestone in Avvio\u2019s journey to expand patient access, improve care, and streamline reimbursement for its groundbreaking approach.<\/p>\n

\n\u201cThe introduction of a dedicated CPT code for our technology demonstrates the clinical importance of our ureteral stone solution,\u201d said Paul Molloy, CEO, Avvio Medical. \u201cThis achievement will help ensure that physicians and health systems can more easily offer our therapy to patients while benefiting from clear and accurate billing processes.\u201d<\/p>\n

\nAvvio worked with expert reimbursement strategy consultants Jeffrey Dann, M.D., and PRIA Healthcare to support the code application process and overall market access planning.<\/p>\n

\nThe announcement was made public as part of the AMA\u2019s official Category III CPT Code <\/strong>Early Release, available here<\/a>.<\/p>\n

\nWhat This Means<\/b><\/p>\n